Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)
Clinical trial NCT02117479 · TERMINATED
Trial details
- NCT number
- NCT02117479
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2016-02-01
- Enrollment
- 321
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.